Clearmind Medicine Stock Forward View
| CMND Stock | USD 2.17 0.02 0.91% |
Clearmind Stock outlook is based on your current time horizon. Investors can use this forecasting interface to forecast Clearmind Medicine stock prices and determine the direction of Clearmind Medicine Common's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Clearmind Medicine's historical fundamentals, such as revenue growth or operating cash flow patterns.
At the present time the rsi of Clearmind Medicine's share price is below 20 suggesting that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 17
Sell Peaked
Oversold | Overbought |
Using Clearmind Medicine hype-based prediction, you can estimate the value of Clearmind Medicine Common from the perspective of Clearmind Medicine response to recently generated media hype and the effects of current headlines on its competitors.
Clearmind Relative Strength Index
The Naive Prediction forecasted value of Clearmind Medicine Common on the next trading day is expected to be 2.01 with a mean absolute deviation of 0.83 and the sum of the absolute errors of 51.56.Clearmind Medicine Common Hype to Price Pattern
Investor biases related to Clearmind Medicine's public news can be used to forecast risks associated with an investment in Clearmind. The trend in average sentiment can be used to explain how an investor holding Clearmind can time the market purely based on public headlines and social activities around Clearmind Medicine Common. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Clearmind Medicine's market sentiment to its price can help taders to make decisions based on the overall investors consensus about Clearmind Medicine.
The Naive Prediction forecasted value of Clearmind Medicine Common on the next trading day is expected to be 2.01 with a mean absolute deviation of 0.83 and the sum of the absolute errors of 51.56. Clearmind Medicine after-hype prediction price | USD 1.36 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Clearmind | Build AI portfolio with Clearmind Stock |
Clearmind Medicine Additional Predictive Modules
Most predictive techniques to examine Clearmind price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Clearmind using various technical indicators. When you analyze Clearmind charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Clearmind Medicine Cash Forecast
Forecasting cash, or other financial indicators, requires analysts to apply different statistical methods, techniques, and algorithms to find hidden patterns within the Clearmind Medicine's financial statements to predict how it will affect future prices.
Cash | First Reported 2016-04-30 | Previous Quarter 3.5 M | Current Value 3.9 M | Quarterly Volatility 2.8 M |
Clearmind Medicine Naive Prediction Price Forecast For the 1st of February
Given 90 days horizon, the Naive Prediction forecasted value of Clearmind Medicine Common on the next trading day is expected to be 2.01 with a mean absolute deviation of 0.83, mean absolute percentage error of 2.16, and the sum of the absolute errors of 51.56.Please note that although there have been many attempts to predict Clearmind Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Clearmind Medicine's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Clearmind Medicine Stock Forecast Pattern
| Backtest Clearmind Medicine | Clearmind Medicine Price Prediction | Buy or Sell Advice |
Clearmind Medicine Forecasted Value
In the context of forecasting Clearmind Medicine's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Clearmind Medicine's downside and upside margins for the forecasting period are 0.02 and 12.80, respectively. We have considered Clearmind Medicine's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Clearmind Medicine stock data series using in forecasting. Note that when a statistical model is used to represent Clearmind Medicine stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 120.7198 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.8316 |
| MAPE | Mean absolute percentage error | 0.1114 |
| SAE | Sum of the absolute errors | 51.56 |
Predictive Modules for Clearmind Medicine
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Clearmind Medicine Common. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Clearmind Medicine After-Hype Price Density Analysis
As far as predicting the price of Clearmind Medicine at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Clearmind Medicine or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Clearmind Medicine, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Clearmind Medicine Estimiated After-Hype Price Volatility
In the context of predicting Clearmind Medicine's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Clearmind Medicine's historical news coverage. Clearmind Medicine's after-hype downside and upside margins for the prediction period are 0.07 and 12.15, respectively. We have considered Clearmind Medicine's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Clearmind Medicine is extremely dangerous at this time. Analysis and calculation of next after-hype price of Clearmind Medicine Common is based on 3 months time horizon.
Clearmind Medicine Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Clearmind Medicine is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Clearmind Medicine backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Clearmind Medicine, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
3.69 | 10.79 | 0.81 | 1.16 | 9 Events / Month | 7 Events / Month | In about 9 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
2.17 | 1.36 | 37.33 |
|
Clearmind Medicine Hype Timeline
Clearmind Medicine Common is currently traded for 2.17. The entity has historical hype elasticity of -0.81, and average elasticity to hype of competition of -1.16. Clearmind is estimated to decline in value after the next headline, with the price expected to drop to 1.36. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -37.33%, whereas the daily expected return is currently at -3.69%. The volatility of related hype on Clearmind Medicine is about 3436.31%, with the expected price after the next announcement by competition of 1.01. About 26.0% of the company shares are held by company insiders. The book value of Clearmind Medicine was currently reported as 7.54. The company recorded a loss per share of 30.35. Clearmind Medicine Common had not issued any dividends in recent years. The entity had 1:40 split on the 15th of December 2025. Given the investment horizon of 90 days the next estimated press release will be in about 9 days. Check out Historical Fundamental Analysis of Clearmind Medicine to cross-verify your projections.Clearmind Medicine Related Hype Analysis
Having access to credible news sources related to Clearmind Medicine's direct competition is more important than ever and may enhance your ability to predict Clearmind Medicine's future price movements. Getting to know how Clearmind Medicine's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Clearmind Medicine may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| TTNP | Titan Pharmaceuticals | (0.02) | 23 per month | 5.38 | 0.04 | 9.38 | (8.08) | 30.41 | |
| SILO | Silo Pharma | 0.03 | 27 per month | 0.00 | (0.18) | 8.33 | (10.00) | 24.79 | |
| KZIA | Kazia Therapeutics Ltd | (2.70) | 8 per month | 10.28 | 0.03 | 14.69 | (18.36) | 78.79 | |
| CANF | Can Fite Biopharma | 0.18 | 9 per month | 0.00 | (0.14) | 10.40 | (8.59) | 38.42 | |
| CNSP | CNS Pharmaceuticals | 0.22 | 7 per month | 0.00 | (0.1) | 7.22 | (7.57) | 26.44 | |
| SNGX | Soligenix | (0.02) | 10 per month | 0.00 | (0.05) | 7.03 | (6.52) | 30.10 | |
| GRI | GRI Bio | (0.86) | 4 per month | 0.00 | (0.29) | 11.88 | (20.75) | 77.14 | |
| CLDI | Calidi Biotherapeutics | (0.06) | 9 per month | 0.00 | (0.15) | 4.90 | (7.14) | 24.52 | |
| JAGX | Jaguar Animal Health | 0.03 | 9 per month | 0.00 | (0.07) | 9.71 | (16.87) | 125.57 | |
| XBIO | Xenetic Biosciences | 0.06 | 6 per month | 0.00 | (0.19) | 4.76 | (6.84) | 18.79 |
Other Forecasting Options for Clearmind Medicine
For every potential investor in Clearmind, whether a beginner or expert, Clearmind Medicine's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Clearmind Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Clearmind. Basic forecasting techniques help filter out the noise by identifying Clearmind Medicine's price trends.Clearmind Medicine Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Clearmind Medicine stock to make a market-neutral strategy. Peer analysis of Clearmind Medicine could also be used in its relative valuation, which is a method of valuing Clearmind Medicine by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Clearmind Medicine Market Strength Events
Market strength indicators help investors to evaluate how Clearmind Medicine stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Clearmind Medicine shares will generate the highest return on investment. By undertsting and applying Clearmind Medicine stock market strength indicators, traders can identify Clearmind Medicine Common entry and exit signals to maximize returns.
Clearmind Medicine Risk Indicators
The analysis of Clearmind Medicine's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Clearmind Medicine's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting clearmind stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 6.95 | |||
| Standard Deviation | 10.45 | |||
| Variance | 109.28 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Clearmind Medicine
The number of cover stories for Clearmind Medicine depends on current market conditions and Clearmind Medicine's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Clearmind Medicine is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Clearmind Medicine's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Clearmind Medicine Short Properties
Clearmind Medicine's future price predictability will typically decrease when Clearmind Medicine's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Clearmind Medicine Common often depends not only on the future outlook of the potential Clearmind Medicine's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Clearmind Medicine's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 127.1 K | |
| Cash And Short Term Investments | 7.8 M |
Check out Historical Fundamental Analysis of Clearmind Medicine to cross-verify your projections. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Will Biotechnology sector continue expanding? Could Clearmind diversify its offerings? Factors like these will boost the valuation of Clearmind Medicine. Projected growth potential of Clearmind fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Clearmind Medicine data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Understanding Clearmind Medicine Common requires distinguishing between market price and book value, where the latter reflects Clearmind's accounting equity. The concept of intrinsic value—what Clearmind Medicine's is actually worth based on fundamentals—guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Clearmind Medicine's price substantially above or below its fundamental value.
It's important to distinguish between Clearmind Medicine's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Clearmind Medicine should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Clearmind Medicine's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.